Literature DB >> 6734368

Circulating hepatocyte membrane-specific autoantibodies in chronic active hepatitis type B. Relation to virus replication activity and liver cell necrosis.

R Meliconi, M Baraldini, A Alberti, F Bortolotti, G Realdi, A Facchini, G Gasbarrini, G Labo.   

Abstract

Sera from two groups of untreated HBsAG-positive patients with chronic active hepatitis on liver biopsy were tested for antibodies to liver cell membrane antigens (liver-specific protein, LSP; and liver membrane antigen, LM-Ag). Among the 14 HBeAg-positive cases, seven (50%) were positive for anti-LSP, whereas only two (13%) of 15 anti-HBe-positive cases circulated this antibody. Liver membrane autoantibody (LMA) was detected only in two sera from delta-positive patients (1 HBeAg positive and 1 anti-HBe positive). Anti-LSP-positive patients presented transaminase values significantly higher than those of the negative cases. Our data do not support the hypothesis that a liver-specific autoimmune mechanism plays a significant role in the immunopathogenesis of liver cell necrosis in anti-HBe-positive chronic active hepatitis type B. The relationship between hepatocyte necrosis and anti-LSP antibody response is confirmed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6734368     DOI: 10.1007/BF01347294

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  Circulating autoantibodies in patients with acute viral hepatitis. Relation to etiology and clinical course.

Authors:  U Tage-Jensen; H Permin; F Hardt; E Juhl; L R Mathiesen; J O Nielsen; L Ranek
Journal:  Scand J Gastroenterol       Date:  1980       Impact factor: 2.423

2.  Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

Authors:  A L Eddleston; R Williams
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

3.  Susceptibility of chronic symptomless HBsAg carriers to ethanol-induced hepatic damage.

Authors:  E Villa; L Rubbiani; T Barchi; I Ferretti; A Grisendi; M De Palma; S Bellentani; F Manenti
Journal:  Lancet       Date:  1982-12-04       Impact factor: 79.321

4.  Liver-cell-membrane autoantibody specific for inflammatory liver diseases.

Authors:  U Tage-Jensen; W Arnold; O Dietrichson; F Hardt; U Hopf; K H Meyer Zum Büschenfelde; J O Nielsen
Journal:  Br Med J       Date:  1977-01-22

5.  Anti-LSP antibodies in acute liver disease.

Authors:  R Meliconi; A Perperas; D Jensen; A Alberti; I G McFarlane; A L Eddleston; R Williams
Journal:  Gut       Date:  1982-07       Impact factor: 23.059

6.  Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg positive chronic liver disease.

Authors:  G Mieli-Vergani; D Vergani; B Portmann; Y White; I Murray-Lyon; J H Marigold; I Woolf; A L Eddleston; R Williams
Journal:  Gut       Date:  1982-12       Impact factor: 23.059

7.  Changes in hepatitis B virus DNA-polymerase activity in patients with chronic infection.

Authors:  A Alberti; P Pontisso; G Realdi
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

8.  Lymphocytotoxicity against autologous hepatocytes and membrane-bound IgG in viral and autoimmune chronic active hepatitis.

Authors:  G F Stefanini; R Meliconi; F Miglio; M Mazzetti; M Baraldini; A Facchini; G Gasbarrini
Journal:  Liver       Date:  1983-02

9.  Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis.

Authors:  D M Jensen; I G McFarlane; B S Portmann; A L Eddleston; R Williams
Journal:  N Engl J Med       Date:  1978-07-06       Impact factor: 91.245

10.  Full and empty Dane particles in chronic hepatitis B virus infection: relation to hepatitis B e antigen and presence of liver damage.

Authors:  A Alberti; S Diana; G H Scullard; W F Eddleston; R Williams
Journal:  Gastroenterology       Date:  1978-11       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.